That "Restructuring" was 2011 and it Failed.
So much irony here. Where to begin?
Provista is not "gearing up for their lung cancer test and Radieny's [sic] CIT technology." A person could also say they are about to add generic Viagra and/or medical marijuana to their pipeline. Wishing out loud on a message board won't make any of this come true.
But what if Provista did want to work with CIT or DR-70? They could probably buy CIT from the Aussies for $200,000 and they can have DR-70 for free. The irony here is: if Provista did these things it would not benefit RXPC shareholders in any way -- in fact it would decrease the already slim chance that RXPC shares will ever trade again. So be careful what you wish for.
Yes, Radient is a private company. The irony here is: Provista can't "go public" through Radient because Radient is not a public company. Capiche?
It's ironic to tout the virtues of AMDL on this message board because RXPC shareholders do not own stock in AMDL. If AMDL rose from the ashes that would not benefit Radient or RXPC shareholders. RXPC shareholders need to wish with all their little hearts that the Aussies do not abandon the Radient Corporation and revive AMDL.
And the irony of mentioning "the Garza report" deserves its own book chapter. If anyone here has not read the "Garza Reports" they should drop everything and do that right now. Never has any stock "analyst" been so 100% wrong. He was wrong about EVERYTHING concerning Radient.
But the final and best irony here is: every link posted on this message board to 2010 and 2011 articles and stories and PR's shows that everything about Radient in 2010-2011 -- every PR, every Garza article, every Silvani interview, every CEO interview, every agreement -- was false.
AI
